CD63 and lung carcinoma: Kristine et al. [11] developed an EV array that paired 37 antibodies that target proteins associated with lung cancer with a panel of CD9, CD63, and CD81 antibodies to examine circulating exosomes from both healthy people and lung cancer patients.